Vitamin D(3) regulates hepatic VEGF-A and apelin expression in experimental type 1 diabetes

• Published in: Ukrainian biochemical journal Vol. 92; no. 4; pp. 5 - 13
• Main Authors: Labudzynskyi, D. O., Shymanskyi, I. O., Lisakovska, O. O., Mazanova, A. O., Natrus, L. V., Veliky, M. M.
• Format: Journal Article
• Language: English
• Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 10.09.2020
• Subjects: angiogenesis; apelin; apoptosis; experimental type 1 diabetes; liver; vegf; vitamin d3
• ISSN: 2409-4943; 2413-5003
• DOI: 10.15407/ubj92.04.005

The deficiency of vitamin D is associated with the risk of various chronic diseases, including diabetes mellitus and its complications. Given the strong genomic action of vitamin D hormone-active form, its deficiency can lead to dysfunction of cytokine signaling pathways, including those dependent on vascular endothelial growth factors (VEGFs) and apelin. The present study was carried out to define the link between VEGF-A and apelin expression in liver, hepatocytes viability and vitamin D status at experimental type 1 diabetes in mice. We established that chronic hyperglycemia at streptozotocin-induced diabetes was accompanied by a 2.2-fold decrease in 25OHD content in the serum and increased hepatocytes apoptosis and necrosis. Vitamin D deficiency correlated with increased apelin and VEGF-A (8- and 1.6-fold respectively) expression. Almost complete restoration of circulatory 25OHD content in serum was achieved at vitamin D3 treatment (800 IU/kg, per os, for 2 months) followed by reduced apelin and VEGF-A expression in liver and the decline of hepatocytes apoptosis. We conclude that vitamin D3 can be involved in cell survival, angiogenesis and fibrogenesis by modulating VEGF-A and apelin dependent regulatory systems in diabetic liver.